大動脈弁の狭窄は細胞外ヘモグロビンの蓄積と全身内皮機能不全を引き起こす
Christine Quast1, Florian Bönner1, Amin Polzin1,2
1Department of Cardiology, Pulmonology and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany (C.Q., F.B., A.P., V.V., R.C., I.G.P., S.P., N.K., M. Nankinova, N.S., E.Z., J.J., F.K., J.H., S.W., K.B., P.L., S. Zako, R.E., C.J., N.G., M.M.C.-K., T.Z., M.K.).
Circulation
|June 5, 2024
まとめ
大動脈狭窄症 (AS) は,血中ヘモグロビンを増加させ,窒素酸化物 (NO) を消費することによって,内皮機能障害を引き起こす. トランスキャテーター大動脈弁置換 (TAVR) は,血液の流れを改善することで,内皮機能を回復します.
科学分野:
- 心血管医学
- 血管生物学
- 血液動力学
背景:
- 大動脈狭窄症 (AS) は,従来の危険因子とは無関係に内皮機能を損なう可能性があります.
- ASの全身内皮機能への直接的な影響は不明である.
研究 の 目的:
- 実験的なASモデルとヒトコホートで内皮と心臓機能を調査する.
- ASが内皮機能に独立して影響するかどうかを判断する.
主な方法:
- TAVRを施したマウスモデルとヒトAS患者を用いた.
- 血流媒介膨張による内皮機能の評価と,血細胞外ヘモグロビン (eHb) と窒素酸化物 (NO) の消費量を測定した.
- 4DフローMRI,計算式流体動力学,および血管リラックスバイオアッセイを使用しました.
主要な成果:
- マウスとヒトにおけるAS誘発の内皮機能不全は,eHbとNOの消費量増加と関連している.
- エンドセリア機能障害と相関する,eHbと赤血球の断片化が増加した.
- ハプトグロービン治療またはTAVRは,eHbを減少させ,または血液動力学を改善することによって,内皮機能を回復させた.
結論:
- ASは,血動力学的変化による血eHbとNOの消費を増加させることで,内皮機能障害を独立して促進する.
- TAVRはNOの吸収を緩和し,血流パターンを正常化することによって内皮機能を改善します.
関連する概念動画
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Esophageal Varices-I: Introduction
107
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
107
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K


